why choose us

First received: September 20, 2022

Clinical Trial: Regeneron AA Multicenter (Dupilumab)

Study Status: Completed

Recruit Status: RECRUITING

Condition: Alopecia Areata

Study Type: INTERVENTIONAL


Official Title: Dupilumab in the Treatment of Alopecia Areata Patients With an Atopic Background and/or High IgE

Brief Summary: This is a prospective, randomized, double blind, placebo-controlled clinical trial.The study will take place at 4 sites.This trial will enroll a total of 68 patients with moderate to severe AA (affecting more than 50% of the scalp) at the time of screening with a targeted 54 subjects completers through Week 48.AA subjects must have evidence of hair regrowth within the last 7 years of their last episode of hair loss; and have screening IgE ? 200 and/or have personal and/or familial history of…

Read more